ARCHIVES

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

Includes May issue of Business & Regulatory Report.

May 31, 2002

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

August 26, 1988

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Executive Branch Should Improve Science Pay, NAS Says

July 16, 1993

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990